Absci Corporation is a generative artificial intelligence (AI) drug creation company. Co. combines AI with scalable wet lab technologies to create biologics for patients. It has built an Integrated Drug Creation platform to identify novel drug targets, discover biotherapeutic candidates, and generate the cell lines to manufacture them in a single process. Co. uses its platform to predict, identify, design, construct, screen, select and scale production of biologic drug candidates for its partners, and learn from the data it generates. Its SoluPro technology is a multiplex synthetic biology approach that overcomes the limitations of highest-throughput automation labs. We show 14 historical shares outstanding datapoints in our coverage of ABSI's shares outstanding history.
Understanding the changing numbers of ABSI shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like ABSI versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching ABSI by allowing them to research ABSI shares outstanding history
as well as any other stock in our coverage universe. |
Free ABSI Email Alerts:
Video: Shares Outstanding Importance
